Journal ArticleOPEN ACCESS

Low molecular weight heparin stimulates megakaryocytopoiesis in bone-marrow transplantation patients

American Journal of Hematology (1996) 53(1) 46-48
DOI: 10.1002/(SICI)1096-8652(199609)53:1<46::AID-AJH11>3.0.CO;2-1
11Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The use of low molecular weight heparin (LMWH) as prophylaxis for veno-occlusive disease of the liver has been studied in patients undergoing bone marrow transplantation (BMT). The present study analyzes the effect of LMWH on the time course of platelet recovery after BMT. Significantly accelerated platelet recovery in conjunction with lessened requirements of platelet transfusions was observed in the LMWH-treated patients.

Author supplied keywords

Cite

CITATION STYLE

APA

Or, R., Elad, S., Shpilberg, O., & Eldor, A. (1996). Low molecular weight heparin stimulates megakaryocytopoiesis in bone-marrow transplantation patients. American Journal of Hematology, 53(1), 46–48. https://doi.org/10.1002/(SICI)1096-8652(199609)53:1<46::AID-AJH11>3.0.CO;2-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free